AU2003227049A1 - Viral mutants, manipulated in the furin cleavage sites of glycoproteins - Google Patents
Viral mutants, manipulated in the furin cleavage sites of glycoproteinsInfo
- Publication number
- AU2003227049A1 AU2003227049A1 AU2003227049A AU2003227049A AU2003227049A1 AU 2003227049 A1 AU2003227049 A1 AU 2003227049A1 AU 2003227049 A AU2003227049 A AU 2003227049A AU 2003227049 A AU2003227049 A AU 2003227049A AU 2003227049 A1 AU2003227049 A1 AU 2003227049A1
- Authority
- AU
- Australia
- Prior art keywords
- glycoproteins
- manipulated
- cleavage sites
- furin cleavage
- viral mutants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02076308.2 | 2002-04-03 | ||
| EP02076308 | 2002-04-03 | ||
| PCT/EP2003/002520 WO2003083095A1 (en) | 2002-04-03 | 2003-03-12 | Viral mutants, manipulated in the furin cleavage sites of glycoproteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003227049A1 true AU2003227049A1 (en) | 2003-10-13 |
Family
ID=28459549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003227049A Abandoned AU2003227049A1 (en) | 2002-04-03 | 2003-03-12 | Viral mutants, manipulated in the furin cleavage sites of glycoproteins |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003227049A1 (en) |
| WO (1) | WO2003083095A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007502623A (en) | 2003-05-09 | 2007-02-15 | リサーチ ディベロップメント ファウンデーション | Insertion of furin protease cleavage site in membrane protein and its use |
| WO2006063445A1 (en) * | 2004-12-14 | 2006-06-22 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health | Recombinant foot and mouth disease vaccine |
| SI3178490T1 (en) * | 2009-07-15 | 2022-08-31 | Glaxosmithkline Biologicals S.A. | Rsv f protein compositions and methods for making same |
| SI3275892T1 (en) | 2011-05-13 | 2020-06-30 | Glaxosmithkline Biologicals S.A. | Pre-fusion rsv f antigens |
-
2003
- 2003-03-12 AU AU2003227049A patent/AU2003227049A1/en not_active Abandoned
- 2003-03-12 WO PCT/EP2003/002520 patent/WO2003083095A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003083095A1 (en) | 2003-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003252473A1 (en) | Composite dispersion and process for producing the same | |
| AU2001269430A1 (en) | Titanium dioxide-calcium carbonate composite particles | |
| AU2002318161A1 (en) | Dye-labeled ribonucleotide triphosphates | |
| AU2003252471A1 (en) | Composite and process for producing the same | |
| AU2003299276A1 (en) | Composite shaped block | |
| AU2003245625A1 (en) | Strand-reinforced elastomeric composite laminates, garments including the laminates, and methods of making the laminates | |
| AU2002300502A1 (en) | Spice Crusher | |
| AU2002952898A0 (en) | Composite beams | |
| AU2002361369A1 (en) | Glass composite | |
| AU2003227049A1 (en) | Viral mutants, manipulated in the furin cleavage sites of glycoproteins | |
| AU2002349135A1 (en) | Composite structural panels | |
| AU2003257312A1 (en) | Composite structural member | |
| AU2003241466A1 (en) | Surface-covering system and methods for making and using the same | |
| AU2003214299A1 (en) | Hiv-1 virus tat-protein mutants | |
| AU4692501A (en) | Laminaribiose phosphorylase, process for producing the same and process for producing laminarioligosaccharide by using the enzyme | |
| AUPR800901A0 (en) | Improved electrolyser | |
| AUPS037002A0 (en) | Viral variants and uses therefor | |
| AU2003267595A1 (en) | Improved composite structures | |
| AU2002304728A1 (en) | Enzymes combination coadjuvating in the interferon therapy | |
| AUPR305601A0 (en) | Composite nail | |
| AU2002308528A1 (en) | Composite particles | |
| AUPR355301A0 (en) | The inclined key joint | |
| AU2002951412A0 (en) | The React-R System and Uses Therefor | |
| AUPS126902A0 (en) | Viral variants and uses therefor-II | |
| AUPS089502A0 (en) | Tilt action with wedge fastener |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |